HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risedronate for the prevention of hip fractures: concern about validity of trials.

AuthorsJutta Martha Halbekath, Stefanie Schenk, Andreas von Maxen, Gabriele Meyer, Ingrid Mühlhauser
JournalArchives of internal medicine (Arch Intern Med) Vol. 167 Issue 5 Pg. 513-4; author reply 514-5 (Mar 12 2007) ISSN: 0003-9926 [Print] United States
PMID17353501 (Publication Type: Letter, Comment)
Chemical References
  • Bone Density Conservation Agents
  • Risedronic Acid
  • Etidronic Acid
Topics
  • Aged
  • Bone Density Conservation Agents (therapeutic use)
  • Etidronic Acid (analogs & derivatives, therapeutic use)
  • Female
  • Follow-Up Studies
  • Hip Fractures (epidemiology, prevention & control)
  • Humans
  • Male
  • Randomized Controlled Trials as Topic (standards)
  • Reproducibility of Results
  • Retrospective Studies
  • Risedronic Acid
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: